Hailey N. Mims

Hailey N. Mims

Auto-generated profile, based on publicly available information

Hailey N. Mims

Department of Chemistry and Biochemistry California State University San Bernardino San Bernardino California USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ACAnthony Castro
Anthony Castro
ARAlfredo Ruiz Rivera
Alfredo Ruiz Rivera
CMChad C. Moorman
Chad C. Moorman
EWEmma R. Wolf-Saxon
Emma R. Wolf-Saxon
HMHailey N. Mims
Hailey N. Mims
JBJason R. Burke
Jason R. Burke
The retinoblastoma tumor suppressor (Rb) is a multifunctional protein that primarily regulates the cell cycle but also has roles in cellular differentiation, DNA damage response, and apoptosis. The loss of Rb is a key event in the development or progression of many cancers. Essential functions of Rb occur through its pocket domain, which is necessary for regulating binding interactions with E2F transcription factors and transcription repressors that bind via an LxCxE motif. The pocket domain is the most highly conserved region of the multidomain protein, as well as the most frequent site of mutations. To understand what effects cancer missense mutations have on Rb's pocket domain, we used fluorescence polarization and differential scanning fluorimetry to quantify changes caused by 75 cancer-associated missense variants to E2F transactivation domain (E2FTD) binding, LxCxE binding, and the thermostability of the pocket domain. We find that 43% of the missense variants tested reduce Rb-E2FTD binding. Many of these variants are not located at the E2FTD-binding site, yet they destabilize the fold of the protein and show temperature-sensitive binding effects. We also find that 21% of tested mutations reduce LxCxE binding, and several mutations selectively disrupt either E2FTD or LxCxE binding. Protein X-ray crystallography of four missense variants reveals how mutations destabilize the protein fold and inhibit E2FTD or LxCxE binding. Taken together, this work provides the first understanding of the multiple ways through which stability, structure, and function of Rb's pocket domain are altered by common missense mutations seen in cancer.

22 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAnthony Castro
Anthony Castro
ARAlfredo Ruiz-Rivera
Alfredo Ruiz-Rivera
CMChad C. Moorman
Chad C. Moorman
EWEmma R. Wolf-Saxon
Emma R. Wolf-Saxon
HMHailey N. Mims
Hailey N. Mims
JBJason R. Burke
Jason R. Burke
The retinoblastoma tumor suppressor (Rb) is a multifunctional protein that primarily regulates the cell cycle but also has roles in cellular differentiation, DNA damage response and apoptosis. The loss of Rb is a key event in the development or progression of many cancers. Essential functions of Rb occur through its pocket domain, which is necessary for regulating binding interactions with E2F transcription factors and transcription repressors that bind via an LxCxE motif. The pocket domain is the most highly-conserved region of the multidomain protein, as well as the most frequent site of mutations. To understand what effects cancer missense mutations have on Rb’s pocket domain, we used fluorescence polarization and differential scanning fluorimetry to quantify changes, caused by 75 cancer-associated missense variants, to E2F transactivation domain (E2F TD ) binding, LxCxE binding, and changes to the thermostability of the protein. We find that 43% of the missense variants we tested reduce Rb-E2F TD binding. Many of these variants are not located at the E2F binding site, yet they destabilize the fold of the protein and show temperature-sensitive binding effects. We also find that 21% of tested mutations reduce LxCxE binding, and several mutations selectively disrupt either E2F TD or LxCxE binding. Protein X-ray crystallography of four missense variants reveals how different mutations destabilize the protein fold and inhibit E2F TD or LxCxE binding. Taken together, this work provides the first understanding of the multiple ways through which stability, structure and function of Rb’s pocket domain is altered by a large number of missense mutations seen in cancer.

16 October 2026 in Plant Direct
Verified
Journal Article
Open access
JBJason R. Burke
Jason R. Burke
MRMatthew A. Rangel
Matthew A. Rangel
VMVanessa I. Vasquez Meza
Vanessa I. Vasquez Meza
HMHailey N. Mims
Hailey N. Mims
TDThomas O. Darko
Thomas O. Darko
CMChad C. Moorman
Chad C. Moorman
Chalcone isomerase (CHI) catalyzes the cyclization of three‐ring scaffolds of flavonoids, a class of plant‐based natural products important for nutrition and disease prevention. A persistent question has been whether the enzyme uses protein dynamics to facilitate conformational rearrangements of substrates within the active site. To help resolve this question, CHI from Medicago truncatula was crystallized with phloretin, a flexible substrate analogue that cannot undergo cyclization, and solved to 2.0‐Å resolution. The crystal structure possesses eight protein molecules per asymmetric unit, revealing different active site conformations that accommodate different bound conformers of phloretin. Together, the structural snapshots depict a series of coordinated, dynamic chemical interactions that lower barriers to substrate rearrangements approaching bond formation. Differential scanning fluorimetry combined with mutational analysis and enzyme kinetics further confirms that phloretin binds to the enzyme active site, and that it acts as a competitive inhibitor of CHI. Together, these findings answer outstanding questions about the flexibility and dynamics of CHI catalysis, information that may be useful for future biosynthetic design and enzyme engineering goals. Overall, this work supports a catalytic model in which the CHI enzyme operates as a dynamic ensemble of structures necessary to facilitate catalytic substrate rearrangements.

3 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJason R. Burke
Jason R. Burke
MRMatthew A. Rangel
Matthew A. Rangel
VMVanessa I. Vasquez Meza
Vanessa I. Vasquez Meza
HMHailey N. Mims
Hailey N. Mims
TDThomas O. Darko
Thomas O. Darko
CMChad C. Moorman
Chad C. Moorman
Chalcone isomerase (CHI) catalyzes the cyclization of 3-ring scaffolds of flavonoids, a class of plant-based natural products important for nutrition and disease prevention. A persistent question has been whether the enzyme uses dynamics to facilitate conformational rearrangements of substrates within the active site. To help resolve this question, CHI was crystallized with phloretin, a flexible substrate analogue that cannot undergo cyclization. The crystal structure possesses eight protein molecules per asymmetric unit, revealing different active site conformations that accommodate different bound conformers of phloretin. Together, the structural snapshots depict a series of coordinated, dynamic chemical interactions that lower barriers to substrate rearrangements approaching bond formation. Differential scanning fluorimetry combined with mutational analysis and enzyme kinetics further confirm that phloretin binds to the enzyme active site and that it acts as a competitive inhibitor of CHI. Together these findings answer outstanding questions about the flexibility and dynamics of CHI catalysis, information that may be useful for future biosynthetic design and enzyme engineering goals. Overall, this work supports a catalytic model in which the CHI enzyme operates as a dynamic ensemble of structures necessary to facilitate catalytic substrate rearrangements.